Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Levothyroxine Sodium in Fibrosis, Liver: NCT05526144 Clinical Landscape Report 2026
15 October 2026
NCT05526144 clinical landscape for Fibrosis, Liver: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dronabinol in Inflammation: NCT05519111 Clinical Landscape Report 2026
15 October 2026
NCT05519111 clinical landscape for Inflammation: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Etavopivat in Anemia, Sickle Cell: LBCTR2022074978 Clinical Landscape Report 2026
15 October 2026
LBCTR2022074978 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ZS-802 in Hemophilia A: NCT05523128 Clinical Landscape Report 2026
15 October 2026
NCT05523128 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Miricorilant in Hepatic Insufficiency: NCT05553470 Clinical Landscape Report 2026
15 October 2026
NCT05553470 clinical landscape for Hepatic Insufficiency: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ARO-MMP7 in Idiopathic Pulmonary Fibrosis: NCT05537025 Clinical Landscape Report 2026
15 October 2026
NCT05537025 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ECC-4703 in Metabolic Dysfunction Associated Steatohepatitis: NCT05552274 Clinical Landscape Report 2026
15 October 2026
NCT05552274 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Gefurulimab in Myasthenia Gravis: NCT05556096 Clinical Landscape Report 2026
15 October 2026
NCT05556096 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zelasudil in Idiopathic Pulmonary Fibrosis: NCT05570058 Clinical Landscape Report 2026
15 October 2026
NCT05570058 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ION-455 in Metabolic Dysfunction Associated Steatohepatitis: NCT05560607 Clinical Landscape Report 2026
15 October 2026
NCT05560607 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Voxelotor in Leg Ulcer: NCT05561140 Clinical Landscape Report 2026
15 October 2026
NCT05561140 clinical landscape for Leg Ulcer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tarperprumig (Alexion) in Anemia, Sickle Cell: NCT05565092 Clinical Landscape Report 2026
15 October 2026
NCT05565092 clinical landscape for Anemia, Sickle Cell: endpoints, sponsor, phase, geography, readouts, asset context and development white space.